Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Micronized Purified Flavonoid Fraction (500mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹130/-
Favodio 500 Tablet contains Micronized Purified Flavonoid Fraction (MPFF), a scientifically formulated blend of flavonoids with active components mainly consisting of diosmin and hesperidin. The micronization process improves absorption, bioavailability, and therapeutic efficacy compared to non-micronized forms. Favodio 500 is a well-recognized venoactive agent that enhances venous tone, reduces venous distension, protects microcirculation, and improves lymphatic drainage. It is widely used in the management of chronic venous insufficiency (CVI), varicose veins, and hemorrhoids. By strengthening vein walls and reducing capillary permeability, it alleviates symptoms such as pain, swelling, leg heaviness, and edema. In hemorrhoidal disease, it helps control inflammation, bleeding, and recurrence. The 500 mg strength is typically prescribed in divided doses for better therapeutic control, especially during acute hemorrhoidal attacks.
Favodio 500 is generally safe and well tolerated. Mild gastrointestinal discomfort such as nausea, abdominal pain, or diarrhea may occur in some patients. Occasional side effects include headache, dizziness, or skin rashes due to hypersensitivity. These effects are typically transient and resolve upon continuation or discontinuation of therapy.
Favodio 500 Tablet is indicated for the management of chronic venous insufficiency, including varicose veins, leg heaviness, pain, edema, and venous ulcers. It is also recommended for the treatment and prevention of acute and chronic hemorrhoidal episodes and as supportive therapy in lymphatic disorders linked to venous stasis.
Favodio 500 should be taken under medical supervision and as part of a comprehensive treatment plan including lifestyle modifications such as avoiding prolonged standing, elevating legs, and maintaining healthy body weight to improve venous return. It is not a replacement for surgical or procedural interventions in advanced venous disease but serves as an effective adjunctive therapy. Favodio 500 is generally considered safe during pregnancy (especially in the second and third trimesters) and lactation under physician guidance. In acute hemorrhoidal crises, adherence to the prescribed dosing schedule is essential for rapid symptom control. Patients with persistent or worsening symptoms should seek medical evaluation to rule out underlying conditions.
Store Favodio 500 Tablet in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use beyond the expiry date printed on the pack.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 5 mg tablet
Composition : Rosuvastatin 5 mg fenofibrate tablet
Composition : Rosuvastatin 40 mg tablet